Janet Hoogstraate

Dr. Janet Hoogstraate is a Chief Executive Officer at NorthX Biologics Matfors AB, an Independent Director at AlzeCure Pharma AB, a Chairman at Stockholm Brain Institute, a Chief Executive Director & Director at Hoogstraate Consulting AB. and a Member-Management Board at Enable2.
She is on the Board of Directors at AlzeCure Pharma AB, Hoogstraate Consulting AB., Apotek Produktion & Laboratorier AB, The Dutch Chamber of Commerce In Sweden and Mireca Medicines GmbH.
Dr. Hoogstraate was previously employed as a Chief Executive Officer by Valneva Sweden AB. She received her MBA from Hult International Business School and a doctorate degree from the University of Leiden.